Labiotech.eu

In Depth 28 Nov 2017

Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?

Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix each of them. Here’s a review of biotech’s progress. Biotech is arguably built on genetic medicine. When Genentech‘s insulin produced by genetically engineered bacteria kicked off biotech fever in the 1980s, the concept of directly repairing defective human DNA wasn’t […]

November 28, 2017 - 8 minutesmins - By Evelyn Warner

News and Trends 27 Nov 2017

Picking the Perfect Time to Strike: How to Stop HIV in its Tracks

In the early stages of infection, the immune system might be able to stop HIV. Austrian researchers have taken a closer look to see what can be done before it’s too late. There has been no shortage of research to find an effective treatment or cure for HIV/AIDS, which affects over 36 million people. Austrian researchers at the […]

November 27, 2017 - 3 minutesmins - By Alex Dale

DNA Tetris Bixels Cell Free Technologies

News and Trends 27 Nov 2017

You Can Now Play DNA Tetris Thanks to This Irish Startup

How cool would it be to program DNA at home to make gifs or play Tetris? Well, this device will soon let you do just that. Cell-Free Technologies wants to take synthetic biology out of the lab and into our homes. This startup based in Cork, Ireland, takes the molecular machinery that cells use to read […]

November 27, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Nov 2017

NASH Leader Signs Up for EU Project to Fight Deadly Liver Disease

Update 27/11/17: Genfit, the leader in the fight against NASH, has joined the LITMUS study. The company will share its experience and resources with the EU collaboration by contributing samples from its RESOLVE-IT clinical study. Genfit will co-lead two projects in patient recruitment and specialized biomarker assays, focusing on genetics and miRNA. Originally published: 23/11/17 […]

November 27, 2017 - 3 minutesmins - By Alex Dale

Interview 27 Nov 2017

A First Treatment for Hearing Loss, Tinnitus and Vertigo? Meet the Man Behind It

Thomas Meyer, CEO of Auris Medical, discusses how biotech can finally bring solutions to those who live with hearing loss, tinnitus and vertigo. Thomas Meyer is at the forefront of a wave of drugs that could, for the first time, show efficacy in treating common hearing disorders. In 2003, he founded Auris Medical to address […]

November 27, 2017 - 10 minutesmins - By Clara Rodríguez Fernández

News and Trends 24 Nov 2017

Let’s Clean Up Our Oceans! New Technique Can Find Even the Tiniest Pieces of Plastic

Current research suggests that we only remove 1% of the plastic waste in our oceans. Thankfully, researchers in the UK have developed a technique to find the rest! Researchers at the University of Warwick, UK, have developed a new and cheap method to find even the smallest bits of plastic that are floating around in […]

November 24, 2017 - 3 minutesmins - By Alex Dale

News and Trends 24 Nov 2017

British SynBio Startup Lands $3.6M for AI-Driven Protein Engineering

LabGenius is using synthetic biology to develop new materials. The funding allows the biotech to set up its own research facility to develop its platform. LabGenius, a new biotech startup based in London, is using artificial intelligence (AI) to drive the development of new materials. This morning, the company has announced that it has received […]

November 24, 2017 - 2 minutesmins - By Alex Dale

Philips consortium cancer angle stilla 1

News and Trends 23 Nov 2017

The EU Gives €6.3M Grant to Anti-Cancer Consortium

The consortium of companies will use the EU’s money to support the development of personalized therapies for breast and rectal cancers. Horizon 2020 is the biggest ever EU Research and Innovation program with almost €80B made available to take exciting science to the market. The initiative has awarded a €6.3M grant to a group of companies brought […]

November 23, 2017 - 2 minutesmins - By Alex Dale

psoriasis treatment approval morphosys 1

News and Trends 23 Nov 2017

Janssen’s Psoriasis Drug is Given a Thumbs Up for Use in Europe

Following its FDA approval in July, MorphoSys’ anti-IL23 antibody has been approved to treat moderate-to-severe psoriasis by the European Commission. German biotech, MorphoSys, is a leader in the field of therapeutic antibodies for series diseases including cancer, arthritis and Alzheimer’s. Today, the company has announced that the licensee, Janssen, has received approval from the European Commission […]

November 23, 2017 - 3 minutesmins - By Alex Dale

Inside Labiotech 23 Nov 2017

Labiotech’s Identity Gets a Makeover

You may have noticed Labiotech has been changing it up a bit, adding a splash of paint and a curvy line here or there. Well, we decided it’s high time we improved our graphic identity. Alfredo has been the mastermind behind these new changes. He has recently joined us from Italy and has been doing […]

November 23, 2017 - 2 minutesmins - By Katherine Douglas

In Depth 23 Nov 2017

The Future is (Syn)Bio: How and when do we get there?

Last week, Philip and I attended a meeting with some of the pioneers and leaders of the synthetic biology field. They believe biology will be everywhere in the future, but how do we get ready for it? Digital technologies are now present in almost all aspects of our lives. It seems obvious today that companies […]

November 23, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 22 Nov 2017

Galapagos Cystic Fibrosis Drug Enters Phase I, Triggering €8.5M Payout

Galapagos will receive a $10M (€8.5M) milestone payment from its collaborator, AbbVie, after their cystic fibrosis candidate started a Phase I trial. Galapagos is a clinical-stage biotech developing small molecule medicines for a range of indications. It partnered up with the global pharma company, AbbVie, back in 2013, to develop a number of cystic fibrosis (CF) candidates for a […]

November 22, 2017 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?

Picking the Perfect Time to Strike: How to Stop HIV in its Tracks

You Can Now Play DNA Tetris Thanks to This Irish Startup

NASH Leader Signs Up for EU Project to Fight Deadly Liver Disease

A First Treatment for Hearing Loss, Tinnitus and Vertigo? Meet the Man Behind It

Let’s Clean Up Our Oceans! New Technique Can Find Even the Tiniest Pieces of Plastic

British SynBio Startup Lands $3.6M for AI-Driven Protein Engineering

The EU Gives €6.3M Grant to Anti-Cancer Consortium

Janssen’s Psoriasis Drug is Given a Thumbs Up for Use in Europe

Labiotech’s Identity Gets a Makeover

The Future is (Syn)Bio: How and when do we get there?

Galapagos Cystic Fibrosis Drug Enters Phase I, Triggering €8.5M Payout

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!